IDEXX Laboratories Inc. (IDXX)

275.68
1.12 0.40
NASDAQ : Health Technology
Prev Close 276.80
Open 277.35
Day Low/High 275.02 / 279.20
52 Wk Low/High 176.11 / 292.17
Volume 165.67K
Avg Volume 384.30K
Exchange NASDAQ
Shares Outstanding 86.09M
Market Cap 23.44B
EPS 4.30
P/E Ratio 58.67
Div & Yield N.A. (N.A)
Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/11/18)

Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/11/18)

Jim Cramer's big takeaways? From cars and homebuilders to chips, he sees pockets of dramatic slowing.

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

Jim Cramer says traders hate hearing about long-term investing because they want instant payoffs.

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Jim Cramer talks about which companies and CEOs are being given the benefit of the doubt -- and which actually deserve it.

Putting IDEXX Laboratories Stock Under the Microscope

Putting IDEXX Laboratories Stock Under the Microscope

After the recent decline, let's see what the charts look like and if there are any signals.

How TheStreet's Editors Would Play the Market Volatility

How TheStreet's Editors Would Play the Market Volatility

U.S. Stocks are set for the strongest gains in six months as global markets rebound. TheStreet's editors give some advice for investors trying to navigate the wild ride.

There Was Change in the Air Today

The narrative is shifting which means the complacency is getting squeezed out of the market.

Idexx Laboratories Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Monster Beverage

Idexx Laboratories Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Monster Beverage

The most recent short interest data has been released for the 07/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IDEXX Laboratories Is Not Responding to Bullish News

IDEXX Laboratories Is Not Responding to Bullish News

Let's review all our charts and indicators.

Idexx Laboratories Moves Up In Analyst Rankings, Passing Constellation Brands

Idexx Laboratories Moves Up In Analyst Rankings, Passing Constellation Brands

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Idexx Laboratories, Inc. has taken over the #47 spot from Constellation Brands Inc , according to ETF Channel.

IDEXX Laboratories Has Been a Real Keeper But a Correction Could Be Coming

IDEXX Laboratories Has Been a Real Keeper But a Correction Could Be Coming

Let's check the indicators and charts.

3 Great Stocks to Buy If You Love Your Pet

3 Great Stocks to Buy If You Love Your Pet

The animal health market continues to be strong, and so is the outlook. Here are several plays on the space and why you should make them.

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.

Idexx Laboratories Becomes #44 Most Shorted Nasdaq 100 Component, Replacing Illumina

Idexx Laboratories Becomes #44 Most Shorted Nasdaq 100 Component, Replacing Illumina

The most recent short interest data has been released for the 06/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Diamondback Energy, Illinois Tool Works, Xerox: 'Mad Money' Lightning Round

Diamondback Energy, Illinois Tool Works, Xerox: 'Mad Money' Lightning Round

Jim Cramer weighs in on Diamondback Energy, Illinois Tool Works, Xerox, PetMed Express, STMicroelectronics, Booking and more.

Time to Cool Off: Cramer's 'Mad Money' Recap (Friday 5/11/18)

Time to Cool Off: Cramer's 'Mad Money' Recap (Friday 5/11/18)

Upcoming earnings? Optimistic spin on trade? Tech rally? Jim Cramer's got the game plan for next week and he tells investors to keep their cool.

Walgreens, Arena Pharma, Dominion Energy: 'Mad Money' Lightning Round

Walgreens, Arena Pharma, Dominion Energy: 'Mad Money' Lightning Round

Jim Cramer focuses on Walgreens Boots Alliance, Arena Pharmaceutical, Dominion Energy, Tower Semiconductor, Idexx, LexinFintech Holdings and more.

FANG, Tariffs, Trade: Cramer's 'Mad Money' Recap (Thursday 4/26/18)

FANG, Tariffs, Trade: Cramer's 'Mad Money' Recap (Thursday 4/26/18)

It's not all about the bond market, says Jim Cramer. The central issues here are trade, tariffs and most important, the stocks themselves, like Facebook and Amazon.

Jim Cramer: Follow the Bouncing Equities

Jim Cramer: Follow the Bouncing Equities

Markets start day with a bungee jump.

Blackberry, SkyWest, Apache: 'Mad Money' Lightning Round

Blackberry, SkyWest, Apache: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Blackberry, SkyWest, Apache, Philip Morris International, PetMed Express, Iron Mountain, Novartis.

Behind the Selloff: Cramer's 'Mad Money' Recap (Friday 4/6/18)

Behind the Selloff: Cramer's 'Mad Money' Recap (Friday 4/6/18)

This market is deceptive and you need to recognize your sense of timing is not infallible. So, adjust your scales and get ready for next week, says Jim Cramer.

IDXX: Insiders vs. Shorts

IDXX: Insiders vs. Shorts

The most recent short interest data was recently released for the 02/28/2018 settlement date, and Idexx Laboratories, Inc. is the #162 most shorted of the S&P 500 components, based on 3.52 "days to cover." There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

STMicroelectronics, PetMed Express: 'Mad Money' Lightning Round

STMicroelectronics, PetMed Express: 'Mad Money' Lightning Round

Jim Cramer focuses on STMicroelectronics, PetMed Express, Lumentum Holdings, and Allergan.

Big Earnings Week Ahead: Cramer's 'Mad Money' Recap (Monday 2/26/18)

Big Earnings Week Ahead: Cramer's 'Mad Money' Recap (Monday 2/26/18)

Jim Cramer is keeping a close eye on retail earnings this week, along with testimony from new Fed Chair Jerome Powell.

General Mills Buys Blue Buffalo for $8 Billion -- Who's Next?

General Mills Buys Blue Buffalo for $8 Billion -- Who's Next?

General Mills is buying Blue Buffalo for $8 billion. It's not the first deal in the pet space and it won't be the last.

Cramer: These Stocks Are on a Mission Right Now

Cramer: These Stocks Are on a Mission Right Now

They are objects that once in motion, stay in motion.

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Jim Cramer says being a realistic investor doesn't mean being negative, especially when solid reality supports optimism.

TheStreet Quant Rating: B (Buy)